<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Cytotoxic-Payloads on Bioecon</title><link>https://en.bioecon.ru/technologies/cytotoxic-payloads/</link><description>Recent content in Cytotoxic-Payloads on Bioecon</description><generator>Hugo</generator><language>en-US</language><atom:link href="https://en.bioecon.ru/technologies/cytotoxic-payloads/index.xml" rel="self" type="application/rss+xml"/><item><title>Antibody-drug conjugates (ADCs)</title><link>https://en.bioecon.ru/technology/antibody-drug-conjugates-adcs/</link><pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/antibody-drug-conjugates-adcs/</guid><description>Targeted oncology therapies utilizing monoclonal antibodies to deliver highly potent cytotoxic payloads directly to cancer cells, minimizing systemic toxicity.</description></item></channel></rss>